NGNE Competitors & Alternatives
Compare Neurogene Inc with similar stocks in the same industry
Biotechnology
NGNE
Main Stock$25.10
Tradestie Score
38
Market Cap
$256.54M
Analyst Upside
+210.3%
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VSTM
Verastem, Inc.
|
$9.09
|
$541.60M | - | 49 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$11.47
|
$540.97M | - | 33 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$11.85
|
$529.35M | 9.8 | 34 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.87
|
$512.39M | - | 41 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$44.52
|
$505.12M | 2.7 | 61 | Compare |
|
RGNX
REGENXBIO Inc.
|
$8.47
|
$493.52M | - | 33 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$90.59
|
$492.21M | - | 47 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.12
|
$468.01M | - | 40 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$10.31
|
$463.20M | - | 43 | Compare |
More NGNE Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry